SCHEMBL16409130

SCHEMBL16409130

CCN(CCc1ccccc1)Cc1ccc2cccc(O)c2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.48
MAOA P21397 4/20 0.48
ACHE P22303 4/20 0.48
OPRK1 P41145 5/20 0.42
OPRM1 P35372 5/20 0.42
OPRD1 P41143 4/20 0.42
DRD3 P35462 3/20 0.42
DRD2 P14416 2/20 0.42
METAP2 P50579 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
CHRM1 P11229 1/20 0.40
DRD1 P21728 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNH2 Q12809 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5595463 0.85 METAP2 (0.50) BCHEMAOAACHEMETAP2CHRM1
SCHEMBL16407649 0.85 BCHE (0.45) BCHEMAOAACHEMETAP2POLB
SCHEMBL2565924 0.83 BCHE (0.53) BCHEMAOAACHEMETAP2POLB
SCHEMBL3306672 0.83 METAP2 (0.47) METAP2HTR1ACHRM1ADRA1APOLB
SCHEMBL16407650 0.79 BCHE (0.44) BCHEMAOAACHEOPRK1OPRM1
SCHEMBL7133311 0.78 KCNH2 (0.56) BCHEMAOAACHEMETAP2CHRM1
SCHEMBL16603424 0.75 BCHE (0.47) BCHEMAOAACHEMETAP2CHRM1
SCHEMBL24454431 0.74 KMT2A (0.48) BCHEMAOAACHEMETAP2CHRM1
SCHEMBL31529406 0.74 KMT2A (0.48) BCHEMAOAACHEMETAP2CHRM1
SCHEMBL18131613 0.73 METAP2 (0.53) METAP2CHRM1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150025108-A1 8-HYDROXY QUINOLINE DERIVATIVES PRANA BIOTECHNOLOGY LIMITED (AU) 2015-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025108-A1 8-HYDROXY QUINOLINE DERIVATIVES PARK7, COQ8A, NLN BCHE 137/4885MAOA 311/4885ACHE 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.